Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Cadisegliatin 800 mg QD
DRUG
2 trials
Sponsors
vTv Therapeutics
Conditions
Diabetes Mellitus, Type 1
Type 1 Diabetes (T1D)
Phase 2
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes Who Are Using Hybrid Closed Loop (HCL) Systems
Not yet recruiting
NCT07616206
vTv Therapeutics
Type 1 Diabetes (T1D)
Start: 2026-07-01
End: 2027-05-01
Target: 40
Updated: 2026-06-01
Phase 3
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Active, not recruiting
NCT06334133
vTv Therapeutics
Diabetes Mellitus, Type 1
Start: 2024-06-14
End: 2027-05-01
Target: 150
Updated: 2026-07-28